nodes	percent_of_prediction	percent_of_DWPC	metapath
Nandrolone phenpropionate—CYP19A1—Endogenous sterols—NR1H4—liver cancer	0.038	0.0415	CbGpPWpGaD
Nandrolone phenpropionate—AR—Nuclear Receptors—NR1I3—liver cancer	0.0291	0.0318	CbGpPWpGaD
Nandrolone phenpropionate—AR—Nuclear Receptor transcription pathway—NR1H4—liver cancer	0.0234	0.0255	CbGpPWpGaD
Nandrolone phenpropionate—AR—Nuclear Receptor transcription pathway—NR1I3—liver cancer	0.023	0.0251	CbGpPWpGaD
Nandrolone phenpropionate—Ethynodiol—ESR1—liver cancer	0.0209	0.248	CrCbGaD
Nandrolone phenpropionate—AR—Nuclear Receptors—HNF4A—liver cancer	0.0202	0.022	CbGpPWpGaD
Nandrolone phenpropionate—AR—FOXA1 transcription factor network—SERPINA1—liver cancer	0.0184	0.0201	CbGpPWpGaD
Nandrolone phenpropionate—Norgestimate—ESR1—liver cancer	0.0178	0.211	CrCbGaD
Nandrolone phenpropionate—CYP19A1—Cytochrome P450 - arranged by substrate type—NR1H4—liver cancer	0.0177	0.0193	CbGpPWpGaD
Nandrolone phenpropionate—AR—Nuclear Receptor transcription pathway—HNF4A—liver cancer	0.0159	0.0174	CbGpPWpGaD
Nandrolone phenpropionate—AR—Coregulation of Androgen receptor activity—TCF4—liver cancer	0.0159	0.0174	CbGpPWpGaD
Nandrolone phenpropionate—Etonogestrel—ESR1—liver cancer	0.0154	0.183	CrCbGaD
Nandrolone phenpropionate—CYP19A1—Phase 1 - Functionalization of compounds—NR1H4—liver cancer	0.0143	0.0156	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Biological oxidations—UGDH—liver cancer	0.013	0.0142	CbGpPWpGaD
Nandrolone phenpropionate—AR—Regulation of nuclear beta catenin signaling and target gene transcription—TCF4—liver cancer	0.0128	0.014	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Tryptophan metabolism—CYP2E1—liver cancer	0.0119	0.013	CbGpPWpGaD
Nandrolone phenpropionate—AR—Regulation of nuclear SMAD2/3 signaling—ATF3—liver cancer	0.0114	0.0124	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—FSH signaling pathway—MAPK14—liver cancer	0.0111	0.0121	CbGpPWpGaD
Nandrolone phenpropionate—AR—Regulation of nuclear SMAD2/3 signaling—HNF4A—liver cancer	0.011	0.012	CbGpPWpGaD
Nandrolone phenpropionate—Levonorgestrel—ESR1—liver cancer	0.0109	0.129	CrCbGaD
Nandrolone phenpropionate—AR—Nuclear Receptors—PPARA—liver cancer	0.0106	0.0116	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Cytochrome P450 - arranged by substrate type—CYP2E1—liver cancer	0.00962	0.0105	CbGpPWpGaD
Nandrolone phenpropionate—AR—Nuclear Receptors—ESR1—liver cancer	0.00959	0.0105	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Oxidation by Cytochrome P450—CYP2E1—liver cancer	0.00949	0.0104	CbGpPWpGaD
Nandrolone phenpropionate—AR—Nuclear Receptors—PPARG—liver cancer	0.00875	0.00956	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Tryptophan metabolism—CYP1A1—liver cancer	0.00855	0.00934	CbGpPWpGaD
Nandrolone phenpropionate—AR—FOXA1 transcription factor network—ESR1—liver cancer	0.00853	0.00932	CbGpPWpGaD
Nandrolone phenpropionate—AR—Nongenotropic Androgen signaling—RAF1—liver cancer	0.00837	0.00915	CbGpPWpGaD
Nandrolone phenpropionate—AR—Nuclear Receptor transcription pathway—PPARA—liver cancer	0.00837	0.00914	CbGpPWpGaD
Nandrolone phenpropionate—AR—Notch-mediated HES/HEY network—KDR—liver cancer	0.0083	0.00907	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—FSH signaling pathway—RAF1—liver cancer	0.00805	0.00879	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—FSH signaling pathway—MTOR—liver cancer	0.00786	0.00858	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Phase 1 - Functionalization of compounds—CYP2E1—liver cancer	0.0078	0.00852	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Biological oxidations—NR1H4—liver cancer	0.0076	0.0083	CbGpPWpGaD
Nandrolone phenpropionate—AR—Nuclear Receptor transcription pathway—ESR1—liver cancer	0.00758	0.00828	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Breast Cancer Pathway—AHR—liver cancer	0.0075	0.00819	CbGpPWpGaD
Nandrolone phenpropionate—AR—Regulation of Androgen receptor activity—MAPK14—liver cancer	0.00749	0.00818	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Biological oxidations—GSTA3—liver cancer	0.00748	0.00816	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metapathway biotransformation—GSTA3—liver cancer	0.00737	0.00805	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Pancreatic Cancer Pathway—FST—liver cancer	0.00712	0.00778	CbGpPWpGaD
Nandrolone phenpropionate—AR—Nuclear Receptor transcription pathway—PPARG—liver cancer	0.00692	0.00755	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Cytochrome P450 - arranged by substrate type—CYP1A1—liver cancer	0.00691	0.00755	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Biological oxidations—GSTA4—liver cancer	0.00684	0.00747	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Oxidation by Cytochrome P450—CYP1A1—liver cancer	0.00682	0.00745	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metapathway biotransformation—GSTA4—liver cancer	0.00674	0.00736	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Biological oxidations—GSTA2—liver cancer	0.00666	0.00728	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Integrated Breast Cancer Pathway—AHR—liver cancer	0.00645	0.00705	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Ovarian Infertility Genes—CDKN1B—liver cancer	0.00644	0.00703	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Biological oxidations—GSTA1—liver cancer	0.00643	0.00702	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Biological oxidations—NAT2—liver cancer	0.00636	0.00694	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metapathway biotransformation—NAT2—liver cancer	0.00627	0.00685	CbGpPWpGaD
Nandrolone phenpropionate—AR—Regulation of nuclear beta catenin signaling and target gene transcription—TERT—liver cancer	0.00593	0.00648	CbGpPWpGaD
Nandrolone phenpropionate—AR—FOXA1 transcription factor network—CDKN1B—liver cancer	0.0058	0.00633	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Phase 1 - Functionalization of compounds—CYP1A1—liver cancer	0.0056	0.00612	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Pancreatic Cancer Pathway—HNF4A—liver cancer	0.00554	0.00605	CbGpPWpGaD
Nandrolone phenpropionate—AR—FOXA1 transcription factor network—JUN—liver cancer	0.00552	0.00603	CbGpPWpGaD
Nandrolone phenpropionate—AR—Notch-mediated HES/HEY network—CDKN1B—liver cancer	0.0055	0.00601	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Pancreatic Cancer Pathway—HPGDS—liver cancer	0.00543	0.00593	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metapathway biotransformation—GPX3—liver cancer	0.00533	0.00582	CbGpPWpGaD
Nandrolone phenpropionate—AR—Regulation of nuclear SMAD2/3 signaling—ESR1—liver cancer	0.00524	0.00572	CbGpPWpGaD
Nandrolone phenpropionate—Progesterone—ESR1—liver cancer	0.00515	0.0611	CrCbGaD
Nandrolone phenpropionate—CYP19A1—Biological oxidations—HPGDS—liver cancer	0.00508	0.00555	CbGpPWpGaD
Nandrolone phenpropionate—AR—Coregulation of Androgen receptor activity—CDKN2A—liver cancer	0.00504	0.00551	CbGpPWpGaD
Nandrolone phenpropionate—AR—Regulation of nuclear beta catenin signaling and target gene transcription—APC—liver cancer	0.005	0.00546	CbGpPWpGaD
Nandrolone phenpropionate—AR—Nongenotropic Androgen signaling—PIK3CA—liver cancer	0.00498	0.00544	CbGpPWpGaD
Nandrolone phenpropionate—AR—Regulation of Androgen receptor activity—JUN—liver cancer	0.00476	0.00519	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism of lipids and lipoproteins—EPT1—liver cancer	0.0047	0.00513	CbGpPWpGaD
Nandrolone phenpropionate—AR—Nongenotropic Androgen signaling—HRAS—liver cancer	0.00461	0.00504	CbGpPWpGaD
Nandrolone phenpropionate—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CDH1—liver cancer	0.0046	0.00502	CbGpPWpGaD
Nandrolone phenpropionate—AR—Notch-mediated HES/HEY network—STAT3—liver cancer	0.00453	0.00495	CbGpPWpGaD
Nandrolone phenpropionate—AR—Regulation of Androgen receptor activity—MAPK8—liver cancer	0.0045	0.00491	CbGpPWpGaD
Nandrolone phenpropionate—AR—Regulation of nuclear beta catenin signaling and target gene transcription—MMP2—liver cancer	0.00443	0.00484	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Breast Cancer Pathway—ABL1—liver cancer	0.00431	0.0047	CbGpPWpGaD
Nandrolone phenpropionate—AR—Regulation of nuclear SMAD2/3 signaling—SERPINE1—liver cancer	0.0043	0.0047	CbGpPWpGaD
Nandrolone phenpropionate—AR—Coregulation of Androgen receptor activity—CCND1—liver cancer	0.00426	0.00465	CbGpPWpGaD
Nandrolone phenpropionate—AR—Coregulation of Androgen receptor activity—CTNNB1—liver cancer	0.00422	0.00461	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Biological oxidations—CYP2E1—liver cancer	0.00414	0.00452	CbGpPWpGaD
Nandrolone phenpropionate—Progesterone—CYP1A1—liver cancer	0.00411	0.0488	CrCbGaD
Nandrolone phenpropionate—CYP19A1—Metapathway biotransformation—CYP2E1—liver cancer	0.00409	0.00446	CbGpPWpGaD
Nandrolone phenpropionate—AR—Nongenotropic Androgen signaling—AKT1—liver cancer	0.00407	0.00445	CbGpPWpGaD
Nandrolone phenpropionate—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CDKN2A—liver cancer	0.00406	0.00443	CbGpPWpGaD
Nandrolone phenpropionate—AR—Generic Transcription Pathway—NR1H4—liver cancer	0.00404	0.00441	CbGpPWpGaD
Nandrolone phenpropionate—AR—Generic Transcription Pathway—NR1I3—liver cancer	0.00397	0.00433	CbGpPWpGaD
Nandrolone phenpropionate—Norethindrone—ALB—liver cancer	0.00393	0.0466	CrCbGaD
Nandrolone phenpropionate—CYP19A1—FSH signaling pathway—AKT1—liver cancer	0.00391	0.00427	CbGpPWpGaD
Nandrolone phenpropionate—Testosterone—CYP1A1—liver cancer	0.00389	0.0461	CrCbGaD
Nandrolone phenpropionate—CYP19A1—Biological oxidations—GGT1—liver cancer	0.0038	0.00415	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Integrated Breast Cancer Pathway—ABL1—liver cancer	0.00371	0.00405	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Pancreatic Cancer Pathway—ABL1—liver cancer	0.00357	0.0039	CbGpPWpGaD
Nandrolone phenpropionate—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CCND1—liver cancer	0.00343	0.00374	CbGpPWpGaD
Nandrolone phenpropionate—AR—Regulation of nuclear beta catenin signaling and target gene transcription—JUN—liver cancer	0.00342	0.00374	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Biological oxidations—GSTP1—liver cancer	0.00342	0.00373	CbGpPWpGaD
Nandrolone phenpropionate—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CTNNB1—liver cancer	0.0034	0.00371	CbGpPWpGaD
Nandrolone phenpropionate—AR—Regulation of nuclear SMAD2/3 signaling—JUN—liver cancer	0.00339	0.0037	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metapathway biotransformation—GSTP1—liver cancer	0.00337	0.00368	CbGpPWpGaD
Nandrolone phenpropionate—AR—Regulation of nuclear beta catenin signaling and target gene transcription—MMP9—liver cancer	0.00333	0.00364	CbGpPWpGaD
Nandrolone phenpropionate—AR—Regulation of nuclear SMAD2/3 signaling—CDKN1A—liver cancer	0.00328	0.00359	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Breast Cancer Pathway—ESR1—liver cancer	0.00318	0.00347	CbGpPWpGaD
Nandrolone phenpropionate—AR—Androgen receptor signaling pathway—CCND1—liver cancer	0.00315	0.00344	CbGpPWpGaD
Nandrolone phenpropionate—AR—Androgen receptor signaling pathway—JUN—liver cancer	0.00314	0.00343	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Biological oxidations—GSTM1—liver cancer	0.00314	0.00343	CbGpPWpGaD
Nandrolone phenpropionate—AR—Androgen receptor signaling pathway—CTNNB1—liver cancer	0.00312	0.0034	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metapathway biotransformation—GSTM1—liver cancer	0.0031	0.00338	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Pancreatic Cancer Pathway—PCNA—liver cancer	0.00306	0.00334	CbGpPWpGaD
Nandrolone phenpropionate—AR—Androgen receptor signaling pathway—CDKN1A—liver cancer	0.00305	0.00333	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism of lipids and lipoproteins—CPT1B—liver cancer	0.00303	0.00331	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Biological oxidations—CYP1A1—liver cancer	0.00298	0.00325	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metapathway biotransformation—CYP1A1—liver cancer	0.00294	0.00321	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism of lipids and lipoproteins—NR1H4—liver cancer	0.00292	0.00319	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Breast Cancer Pathway—BRAF—liver cancer	0.00283	0.00309	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Breast Cancer Pathway—CDH1—liver cancer	0.00277	0.00302	CbGpPWpGaD
Nandrolone phenpropionate—AR—Generic Transcription Pathway—HNF4A—liver cancer	0.00275	0.003	CbGpPWpGaD
Nandrolone phenpropionate—AR—Regulation of nuclear beta catenin signaling and target gene transcription—MYC—liver cancer	0.00275	0.003	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Integrated Breast Cancer Pathway—ESR1—liver cancer	0.00274	0.00299	CbGpPWpGaD
Nandrolone phenpropionate—AR—Regulation of nuclear SMAD2/3 signaling—MYC—liver cancer	0.00272	0.00297	CbGpPWpGaD
Nandrolone phenpropionate—AR—Androgen receptor signaling pathway—STAT3—liver cancer	0.00272	0.00297	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Pancreatic Cancer Pathway—MAPK14—liver cancer	0.00269	0.00293	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Pancreatic Cancer Pathway—ESR1—liver cancer	0.00264	0.00288	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Pancreatic Cancer Pathway—APC—liver cancer	0.00249	0.00272	CbGpPWpGaD
Nandrolone phenpropionate—AR—Gene Expression—EXOSC2—liver cancer	0.00244	0.00267	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Integrated Breast Cancer Pathway—BRAF—liver cancer	0.00243	0.00266	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Integrated Breast Cancer Pathway—CDH1—liver cancer	0.00238	0.0026	CbGpPWpGaD
Nandrolone phenpropionate—AR—Coregulation of Androgen receptor activity—AKT1—liver cancer	0.00237	0.00259	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Breast Cancer Pathway—MTOR—liver cancer	0.0023	0.00252	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism of lipids and lipoproteins—CRABP1—liver cancer	0.00223	0.00244	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—UGDH—liver cancer	0.00223	0.00243	CbGpPWpGaD
Nandrolone phenpropionate—Testosterone—ALB—liver cancer	0.00217	0.0257	CrCbGaD
Nandrolone phenpropionate—AR—Integrated Breast Cancer Pathway—CASP3—liver cancer	0.00212	0.00231	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—EPT1—liver cancer	0.00209	0.00229	CbGpPWpGaD
Nandrolone phenpropionate—AR—SIDS Susceptibility Pathways—CASP3—liver cancer	0.00206	0.00225	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Breast Cancer Pathway—CCND1—liver cancer	0.00206	0.00225	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Breast Cancer Pathway—JUN—liver cancer	0.00206	0.00225	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Breast Cancer Pathway—CTNNB1—liver cancer	0.00204	0.00223	CbGpPWpGaD
Nandrolone phenpropionate—AR—SIDS Susceptibility Pathways—JUN—liver cancer	0.00201	0.00219	CbGpPWpGaD
Nandrolone phenpropionate—AR—SIDS Susceptibility Pathways—CTNNB1—liver cancer	0.00199	0.00217	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—TAT—liver cancer	0.00198	0.00217	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Integrated Breast Cancer Pathway—MTOR—liver cancer	0.00198	0.00216	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Pancreatic Cancer Pathway—RAF1—liver cancer	0.00196	0.00214	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism of lipids and lipoproteins—HPGDS—liver cancer	0.00195	0.00213	CbGpPWpGaD
Nandrolone phenpropionate—AR—Gene Expression—NR1H4—liver cancer	0.00194	0.00212	CbGpPWpGaD
Nandrolone phenpropionate—AR—Gene Expression—NR1I3—liver cancer	0.00191	0.00209	CbGpPWpGaD
Nandrolone phenpropionate—AR—Regulation of nuclear SMAD2/3 signaling—AKT1—liver cancer	0.00189	0.00206	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Integrated Breast Cancer Pathway—CASP3—liver cancer	0.00182	0.00199	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Breast Cancer Pathway—VEGFA—liver cancer	0.0018	0.00196	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Pancreatic Cancer Pathway—CDKN1B—liver cancer	0.00179	0.00196	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Integrated Breast Cancer Pathway—CCND1—liver cancer	0.00177	0.00194	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Integrated Breast Cancer Pathway—JUN—liver cancer	0.00177	0.00193	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Integrated Breast Cancer Pathway—CTNNB1—liver cancer	0.00176	0.00192	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Pancreatic Cancer Pathway—CASP3—liver cancer	0.00176	0.00192	CbGpPWpGaD
Nandrolone phenpropionate—AR—SIDS Susceptibility Pathways—VEGFA—liver cancer	0.00175	0.00191	CbGpPWpGaD
Nandrolone phenpropionate—AR—Androgen receptor signaling pathway—AKT1—liver cancer	0.00175	0.00191	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Pancreatic Cancer Pathway—CCND1—liver cancer	0.00171	0.00187	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Pancreatic Cancer Pathway—JUN—liver cancer	0.00171	0.00186	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Pancreatic Cancer Pathway—CTNNB1—liver cancer	0.00169	0.00185	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Breast Cancer Pathway—MYC—liver cancer	0.00165	0.00181	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Pancreatic Cancer Pathway—CDKN1A—liver cancer	0.00165	0.00181	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Pancreatic Cancer Pathway—MAPK8—liver cancer	0.00161	0.00176	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Integrated Breast Cancer Pathway—VEGFA—liver cancer	0.00155	0.00169	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Breast Cancer Pathway—KRAS—liver cancer	0.00153	0.00167	CbGpPWpGaD
Nandrolone phenpropionate—AR—SIDS Susceptibility Pathways—TNF—liver cancer	0.0015	0.00164	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Pancreatic Cancer Pathway—VEGFA—liver cancer	0.00149	0.00163	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism of lipids and lipoproteins—GGT1—liver cancer	0.00146	0.0016	CbGpPWpGaD
Nandrolone phenpropionate—AR—Generic Transcription Pathway—PPARA—liver cancer	0.00145	0.00158	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Integrated Breast Cancer Pathway—MYC—liver cancer	0.00142	0.00155	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Pancreatic Cancer Pathway—MYC—liver cancer	0.00137	0.0015	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Pancreatic Cancer Pathway—TGFB1—liver cancer	0.00137	0.00149	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Breast Cancer Pathway—TP53—liver cancer	0.00136	0.00148	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—CPT1B—liver cancer	0.00135	0.00147	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—GLUL—liver cancer	0.00135	0.00147	CbGpPWpGaD
Nandrolone phenpropionate—AR—Gene Expression—HNF4A—liver cancer	0.00132	0.00145	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Integrated Breast Cancer Pathway—KRAS—liver cancer	0.00132	0.00144	CbGpPWpGaD
Nandrolone phenpropionate—AR—Generic Transcription Pathway—ESR1—liver cancer	0.00131	0.00143	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—NR1H4—liver cancer	0.0013	0.00142	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—GSTA3—liver cancer	0.00128	0.0014	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Pancreatic Cancer Pathway—TNF—liver cancer	0.00128	0.00139	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Pancreatic Cancer Pathway—KRAS—liver cancer	0.00127	0.00138	CbGpPWpGaD
Nandrolone phenpropionate—AR—SIDS Susceptibility Pathways—IL6—liver cancer	0.00121	0.00132	CbGpPWpGaD
Nandrolone phenpropionate—AR—Generic Transcription Pathway—PPARG—liver cancer	0.00119	0.0013	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—GSTA4—liver cancer	0.00117	0.00128	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Integrated Breast Cancer Pathway—TP53—liver cancer	0.00117	0.00128	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Pancreatic Cancer Pathway—PIK3CA—liver cancer	0.00116	0.00127	CbGpPWpGaD
Nandrolone phenpropionate—AR—Gene Expression—PSMD10—liver cancer	0.00116	0.00126	CbGpPWpGaD
Nandrolone phenpropionate—AR—Gene Expression—PSMA4—liver cancer	0.00116	0.00126	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Breast Cancer Pathway—AKT1—liver cancer	0.00115	0.00125	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism of lipids and lipoproteins—CYP1A1—liver cancer	0.00114	0.00125	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—GSTA2—liver cancer	0.00114	0.00124	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Pancreatic Cancer Pathway—TP53—liver cancer	0.00113	0.00123	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—GSTA1—liver cancer	0.0011	0.0012	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—NAT2—liver cancer	0.00109	0.00119	CbGpPWpGaD
Nandrolone phenpropionate—AR—Generic Transcription Pathway—SERPINE1—liver cancer	0.00108	0.00118	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism of lipids and lipoproteins—PPARA—liver cancer	0.00105	0.00114	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—ALDOB—liver cancer	0.00104	0.00114	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—CRABP1—liver cancer	0.000994	0.00109	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Integrated Breast Cancer Pathway—AKT1—liver cancer	0.000987	0.00108	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Pancreatic Cancer Pathway—AKT1—liver cancer	0.000951	0.00104	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism of lipids and lipoproteins—PIK3CG—liver cancer	0.000895	0.000978	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—HPGDS—liver cancer	0.000869	0.000949	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism of lipids and lipoproteins—PPARG—liver cancer	0.000864	0.000944	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism of lipids and lipoproteins—PIK3CD—liver cancer	0.000787	0.000859	CbGpPWpGaD
Nandrolone phenpropionate—AR—Gene Expression—H2AFX—liver cancer	0.000782	0.000854	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism of lipids and lipoproteins—ALB—liver cancer	0.000777	0.000848	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—PSMD10—liver cancer	0.000775	0.000846	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—PSMA4—liver cancer	0.000775	0.000846	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—GOT2—liver cancer	0.000754	0.000823	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—CYP2E1—liver cancer	0.000708	0.000774	CbGpPWpGaD
Nandrolone phenpropionate—AR—Gene Expression—PPARA—liver cancer	0.000696	0.00076	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	0.000686	0.000749	CbGpPWpGaD
Nandrolone phenpropionate—AR—Generic Transcription Pathway—MYC—liver cancer	0.000681	0.000744	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—CYCS—liver cancer	0.000663	0.000724	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—GGT1—liver cancer	0.00065	0.00071	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—GOT1—liver cancer	0.00065	0.00071	CbGpPWpGaD
Nandrolone phenpropionate—AR—Gene Expression—MAPK14—liver cancer	0.000643	0.000702	CbGpPWpGaD
Nandrolone phenpropionate—AR—Gene Expression—ESR1—liver cancer	0.00063	0.000688	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—GSTP1—liver cancer	0.000584	0.000638	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—HMOX1—liver cancer	0.000576	0.000629	CbGpPWpGaD
Nandrolone phenpropionate—AR—Gene Expression—PPARG—liver cancer	0.000575	0.000628	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—GSTM1—liver cancer	0.000537	0.000586	CbGpPWpGaD
Nandrolone phenpropionate—AR—Gene Expression—SERPINE1—liver cancer	0.000518	0.000566	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—CYP1A1—liver cancer	0.000509	0.000556	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—MTHFR—liver cancer	0.000475	0.000518	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—PPARA—liver cancer	0.000466	0.000508	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	0.000418	0.000457	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—PIK3CG—liver cancer	0.000399	0.000435	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—PPARG—liver cancer	0.000385	0.00042	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—PIK3CD—liver cancer	0.00035	0.000383	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—ALB—liver cancer	0.000346	0.000378	CbGpPWpGaD
Nandrolone phenpropionate—AR—Gene Expression—MYC—liver cancer	0.000328	0.000358	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—PIK3CB—liver cancer	0.000305	0.000334	CbGpPWpGaD
Nandrolone phenpropionate—AR—Gene Expression—AKT1—liver cancer	0.000227	0.000248	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—PIK3CA—liver cancer	0.000186	0.000203	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—AKT1—liver cancer	0.000152	0.000166	CbGpPWpGaD
